Pdt Partners, LLC Alnylam Pharmaceuticals, Inc. Transaction History

Pdt Partners, LLC

$981 Million
Q2 2024

A detailed history of Pdt Partners, LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 14,284 shares of ALNY stock, worth $3.92 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

14,284

Holding current value

$3.92 Million

% of portfolio

0.35%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$143.31 - $247.0 $2.05 Million - $3.53 Million	14,284 New	14,284 $3.47 Million
Q4 2023 Feb 14, 2024	SELL	$151.41 - $196.57 $1.29 Million - $1.68 Million	-8,551 Reduced 59.11%	5,916 $1.13 Million
Q3 2023 Nov 14, 2023	BUY	$170.77 - $211.65 $2.47 Million - $3.06 Million	14,467 New	14,467 $2.56 Million
Q1 2021 May 17, 2021	SELL	$126.83 - $175.69 $1.12 Million - $1.55 Million	-8,800 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$122.97 - $147.0 $1.08 Million - $1.29 Million	8,800 New	8,800 $1.14 Million
Q2 2020 Aug 14, 2020	SELL	$104.21 - $156.44 $7.12 Million - $10.7 Million	-68,313 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$93.12 - $133.99 $4.53 Million - $6.53 Million	-48,700 Reduced 41.62%	68,313 $7.44 Million
Q4 2019 Feb 14, 2020	SELL	$74.51 - $124.23 $380,001 - $633,573	-5,100 Reduced 4.18%	117,013 $13.5 Million
Q3 2019 Nov 14, 2019	SELL	$70.9 - $87.82 $1.18 Million - $1.47 Million	-16,687 Reduced 12.02%	122,113 $9.82 Million
Q2 2019 Aug 14, 2019	BUY	$65.86 - $92.79 $4.2 Million - $5.91 Million	63,722 Added 84.87%	138,800 $10.1 Million
Q1 2019 May 15, 2019	BUY	$72.76 - $93.45 $5.46 Million - $7.02 Million	75,078 New	75,078 $7.02 Million
Q4 2017 Feb 14, 2018	SELL	$114.49 - $139.98 $27.2 Million - $33.3 Million	-237,626 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$72.53 - $118.27 $17.2 Million - $28.1 Million	237,626	237,626 $27.9 Million

Others Institutions Holding ALNY

# of Institutions

614

Shares Held

108M

Call Options Held

2.33M

Put Options Held

2.17M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $33.8B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Account